| Market Cap | ₹1,376Cr |
| ROE | 8.75% |
| P/E Ratio(TTM) | 35.61 |
| EPS(TTM) | 45.42 |
| P/B Ratio | 4.38 |
| Dividend Yield | 0.43% |
| Industry P/E | 34.73 |
| Book Value | 369.41 |
| Debt to Equity | 0.68 |
| Face Value | 10 |
| Parent Organisation | Hester Biosciences |
| Managing Director | Mr. Rajiv Gandhi |
| NSE Symbol | HESTERBIO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.85 | ||
| Gland Pharma | NA (0.00%) | 40.72 | ||
| Ajanta Pharma | NA (0.00%) | 33.06 | ||
| Eris Lifesciences | NA (0.00%) | 53.97 |